HLB Life Science Co., Ltd. (067630.KQ) KOE

Currency In KRW

AD

Valuation

Market Cap472.43B
Enterprise Value619.49B
P/E Ratio-3.96
PEG Ratio0.01
Price/Sales Ratio3.88
Price/Book Ratio0.68
Enterprise/Revenue6.78
Enterprise/EBITDA-5.6

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.98
Operating Margin-0.43
AD

Management Effectiveness

Return On Assets-0.1
Return On Equity-0.17

Income Statement

Revenue45.75B
Revenue/Share422.76
Gross Profit-2.04B
EBITDA-15.84B
Net Income-99.85B
Diluted EPS-818.99

Balance Sheet

Total Cash14.53B
Total Cash/Share119.21
Total Debt164.07B
Total Debt/Equity0.56
Current Ratio0.55
Book Value Per Share2,412.7

Price History

52-Week Change-68.46
52-Week High5,650
52-Week Low1,640
Moving Average 50 Days3,388.8
Moving Average 200 Days3,849.23

Statistics

Average Volume324,860
Shares Outstanding121.85M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor525849:500000
Last Split DateDecember 28, 2022
AD